Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Modulation of gentamicin-induced acute kidney injury by myo-inositol oxygenase via the ROS/ALOX-12/12-HETE/GPR31 signaling pathway
Isha Sharma, Yingjun Liao, Xiaoping Zheng, Yashpal S. Kanwar
Isha Sharma, Yingjun Liao, Xiaoping Zheng, Yashpal S. Kanwar
View: Text | PDF
Research Article Nephrology

Modulation of gentamicin-induced acute kidney injury by myo-inositol oxygenase via the ROS/ALOX-12/12-HETE/GPR31 signaling pathway

  • Text
  • PDF
Abstract

In this investigation, a potentially novel signaling pathway in gentamicin-induced acute kidney injury—worsened by overexpression of proximal tubular enzyme, myo-inositol oxygenase (MIOX)—was elucidated. WT, MIOX-transgenic (MIOX-Tg), and MIOX-KO mice were used. Gentamicin was administered to induce tubular injury. MIOX-Tg mice had severe tubular lesions associated with increased serum creatinine and proteinuria. Lesions were relatively mild, with no rise in serum creatinine and no albuminuria in MIOX-KO mice. Transfection of HK-2 cells with MIOX-pcDNA led to increased gentamicin-induced reactive oxygen species (ROS). Marked increase of ROS-mediated lipid hydroperoxidation was noted in MIOX-Tg mice, as assessed by 4-HNE staining. This was associated with increased expression of arachidonate 12-lipoxygenase (ALOX-12) and generation of 12-hydroxyeicosatetraenoic acid (12-HETE). In addition, notable monocyte/macrophage influx, upregulation of NF-κB and inflammatory cytokines, and apoptosis was observed in MIOX-Tg mice. Treatment of cells with ALOX-12 siRNA abolished gentamicin-mediated induction of cytokines and 12-HETE generation. HETE-12 treatment promoted this effect, along with upregulation of various signaling kinases and activation of GPCR31. Similarly, treatment of cells or mice with the ALOX-12 inhibitor ML355 attenuated inflammatory response, kinase signaling cascade, and albuminuria. Collectively, these studies highlight a potentially novel mechanism (i.e., the ROS/ALOX-12/12-HETE/GPR31 signaling axis) relevant to gentamicin-induced nephrotoxicity modulated by MIOX.

Authors

Isha Sharma, Yingjun Liao, Xiaoping Zheng, Yashpal S. Kanwar

×

Figure 9

Blocking of 12-HETE restores cellular integrity, expression of inflammatory cytokines, and renal functional parameters following gentamicin-induced injury in mice.

Options: View larger image (or click on image) Download as PowerPoint
Blocking of 12-HETE restores cellular integrity, expression of inflammat...
The mice receiving gentamicin had cytolysis, vacuolization of epithelia and loss of tubular brush border (A, B, and L). With the concomitant administration of ML355, normal morphological features of tubular epithelia were largely restored (B, C, and L) (n = 5; ****P ≤ 0.0001 compared with control PBS group; #P ≤ 0.01 as compared with GEN group; 1-way ANOVA with Dunn’s multiple-comparison test). The attenuation of apoptosis can be compared to WT samples (D). In addition, the gentamicin-induced cellular apoptosis was reduced with ML355 administration (E versus F). Scale bars: 50 μm. Also, the expression of marker of tubular renal injury (KIM-1) and inflammatory cytokines was reduced (G–J) (n = 3 independent experiments with 2 duplicates each; *P ≤ 0.05, **P ≤ 0.01, ****P ≤ 0.0001, compared with control PBS group; #P ≤ 0.01, compared with GEN group; 1-way ANOVA with Dunn’s multiple-comparison test). Interestingly, urinary protein excretion was restored to normal and gentamicin-induced albuminuria mitigated (K). G + ML355, gentamicin + ML355.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts